GSK PLC (GSK)
Clinical trial NCT03152669 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2028-04-30 → 2025-07-05 3. primary completion date: 2028-04-30 → 2025-07-05 4. enrollment: 3500 → 1183 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical